99 related articles for article (PubMed ID: 8524695)
1. [The effect of human recombinant erythropoietin on levels of plasma phospholipids in patients chronically treated with hemodialysis].
Krawczyk W; Dmoszyńska A; Ledwozyw A; Marczewski K
Pol Arch Med Wewn; 1995 Jul; 94(1):21-5. PubMed ID: 8524695
[TBL] [Abstract][Full Text] [Related]
2. [The effect of human recombinant erythropoietin on distribution of membrane phospholipids in blood platelets of patients with uremia treated with repeated hemodialysis].
Krawczyk W; Ledwozyw A; Dmoszyńska A; Krzywicka A; Rózyc P
Pol Arch Med Wewn; 1997 Feb; 97(2):120-5. PubMed ID: 9312760
[TBL] [Abstract][Full Text] [Related]
3. Human erythropoietin improves the blood platelet phospholipid composition in chronically hemodialyzed patients.
Krawczyk W; Dmoszyńska A; Marczewski K; Ledwozyw A
Exp Nephrol; 1995; 3(4):265-6. PubMed ID: 8590040
[TBL] [Abstract][Full Text] [Related]
4. [Effect of human recombinant erythropoietin (rhuEPO) on platelet phospholipids in chronically hemodialysed].
Krawczyk W; Dmoszyńska A; Ledwozyw A; Soroka-Wojtaszko M
Acta Haematol Pol; 1993; 24(4):327-31. PubMed ID: 8303978
[TBL] [Abstract][Full Text] [Related]
5. [The influence of recombinant human erythropoietin on platelet phospholipid fatty acid composition in patients on long term hemodialysis].
Krawczyk W; Dmoszyńska A; Ledwozyw A
Pol Merkur Lekarski; 1996 Dec; 1(6):394-7. PubMed ID: 9273229
[TBL] [Abstract][Full Text] [Related]
6. Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Am J Nephrol; 2006; 26(5):497-502. PubMed ID: 17119331
[TBL] [Abstract][Full Text] [Related]
7. The effect of recombinant human erythropoietin (r-Hu EPO) administration on the blood chemistries and composition in uremic rats.
Kozioł M; Ksiazek P; Feldo M; Spasiewicz D; Michalak J; Kleinrok Z
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():61-6. PubMed ID: 8192533
[TBL] [Abstract][Full Text] [Related]
8. The acute effect of intravenously administered recombinant human erythropoietin on the immune response of uremic patients maintained on regular hemodialysis.
William J; Saad N; Salib M; Riad H; Mahran KS; Iskander I; Cozma G; Barsoum R
Artif Organs; 1998 Mar; 22(3):192-6. PubMed ID: 9527278
[TBL] [Abstract][Full Text] [Related]
9. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
Adamowicz A; Trafikowska U; Trafikowska A; Zachara B; Manitius J
Med Sci Monit; 2002 Mar; 8(3):CR202-5. PubMed ID: 11887037
[TBL] [Abstract][Full Text] [Related]
10. Effects of erythropoietin and aminoguanidine on red blood cell deformability in diabetic azotemic and uremic patients.
Brown CD; Zhao ZH; Thomas LL; deGroof R; Friedman EA
Am J Kidney Dis; 2001 Dec; 38(6):1414-20. PubMed ID: 11728984
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant human erythropoietin in uremic patients in substitute treatment].
Canaud B; Mion C
Rev Prat; 1992 Feb; 42(4):432-40. PubMed ID: 1604162
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and uremic platelet aggregation in vivo and in vitro.
Malyszko JS; Malyszko J; Pawlak K; Mysliwiec M
Int J Clin Lab Res; 1996; 26(3):199-202. PubMed ID: 8905452
[TBL] [Abstract][Full Text] [Related]
13. [Does long-term human recombinant erythropoietin (rHuEPO) influence secretion of hormones regulating volume and pressure of arterial blood?].
Rudka R; Kokot F; Wiecek A; Marcinkowski W; Trembecki J
Pol Arch Med Wewn; 1994 Aug; 92(2):154-61. PubMed ID: 7800584
[TBL] [Abstract][Full Text] [Related]
14. Influence of long-term recombinant human erythropoietin (rHuEpo) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients.
Kokot F; Wiecek A; Mesjasz J; Adamczak M; Spiechowicz U
Nephrol Dial Transplant; 1998 May; 13(5):1200-5. PubMed ID: 9623554
[TBL] [Abstract][Full Text] [Related]
15. Influence of long-term erythropoietin treatment on plasma levels of calcium-phosphate related hormones in haemodialyzed uraemic patients.
Kokot F; Wiecek A; Marcinkowski W; Schmidt-Gayk H; Rudka R; Trembecki J
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():9-16. PubMed ID: 8192535
[TBL] [Abstract][Full Text] [Related]
16. [Influence of long-term treatment with human recombinant erythropoietin on secretion of hormones regulating carbohydrate metabolism in hemodialyzed patients with chronic uremia].
Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Pol Arch Med Wewn; 1995 Dec; 94(6):488-94. PubMed ID: 8618811
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of anemia in patients after long term hemodialysis with human recombinant erythropoietin].
Boratyńska M; Mazanowska O; Szewczyk Z
Pol Merkur Lekarski; 1996 Nov; 1(5):329-31. PubMed ID: 9273209
[TBL] [Abstract][Full Text] [Related]
18. Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia.
De Marchi S; Cecchin E; Villalta D; Sepiacci G; Santini G; Bartoli E
N Engl J Med; 1992 Apr; 326(15):969-74. PubMed ID: 1545849
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin response and route of administration.
Taylor JE; Belch JJ; Fleming LW; Mactier RA; Henderson IS; Stewart WK
Clin Nephrol; 1994 May; 41(5):297-302. PubMed ID: 8050210
[TBL] [Abstract][Full Text] [Related]
20. Selenium and glutathione levels, and glutathione peroxidase activities in blood components of uremic patients on hemodialysis supplemented with selenium and treated with erythropoietin.
Zachara BA; Adamowicz A; Trafikowska U; Trafikowska A; Manitius J; Nartowicz E
J Trace Elem Med Biol; 2001; 15(4):201-8. PubMed ID: 11846008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
